PSRF:LSE:LSE-Invesco Markets III plc - Invesco FTSE RAFI US 1000 UCITS ETF (GBX)

ETF | Others |

Last Closing

USD 2450.5

Change

0.00 (0.00)%

Market Cap

USD 0.49B

Volume

4.20K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-05 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

N/A

USD 292,109.69B
XMTD:LSE Xtrackers MSCI Taiwan UCITS ET..

N/A

USD 292,109.19B
0R15:LSE SoftBank Group Corp.

N/A

USD 9,217.80B
0R1E:LSE Nintendo Co. Ltd.

N/A

USD 7,596.04B
0R1O:LSE Amazon.com Inc.

N/A

USD 1,607.29B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

N/A

USD 652.47B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

N/A

USD 650.46B
0R1I:LSE NVIDIA Corp.

N/A

USD 618.20B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
XDJP:LSE Xtrackers Nikkei 225 UCITS ETF..

N/A

USD 330.91B

ETFs Containing PSRF:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.94% 72% C 68% D+
Dividend Return 0.00% 23% F 15% F
Total Return 6.94% 71% C- 68% D+
Trailing 12 Months  
Capital Gain 20.11% 76% C+ 76% C+
Dividend Return 0.01% 20% F 12% F
Total Return 20.12% 76% C+ 76% C+
Trailing 5 Years  
Capital Gain 67.38% 81% B- 83% B
Dividend Return 0.03% 13% F 7% C-
Total Return 67.42% 79% B- 81% B-
Average Annual (5 Year Horizon)  
Capital Gain 11.10% 75% C 76% C+
Dividend Return 11.10% 75% C 75% C
Total Return 0.00% 60% D- 9% A-
Risk Return Profile  
Volatility (Standard Deviation) 14.32% 52% F 66% D+
Risk Adjusted Return 77.55% 89% A- 93% A
Market Capitalization 0.49B 70% C- 59% D-

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike